维普中文期刊产品整合服务
117篇 您的检索式:作者名="Carson PE"
    题名 作者 年代 出处 被引量
1Valsartan reduces the incidence of artrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trail(Val -HeFT)显示文摘 Latini R Carson PE 2005Am Heart J2005,149,3:1
2Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT) 显示文摘Maggloni AP Latini R Carson PE 2005Am Heart J2005,149,3:1
3Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (Val-HeFT)显示文摘Maggioni AP Latini R Carson PE 2005Am Heart J2005,149,:1
4Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from valsartan heart failure trial(Val-HeFT) 显示文摘Maggioni AP Latini R Carson PE 2005Am Heart J2005,149,:1
5Incidence of thromboembolic events in congestive heart failure显示文摘Dunkman WB Johnson GR Carson PE 1993Circulation1993,87,:1
6Irbesartan in patients with heart failure and preserved ejection fraction显示文摘Massie BM Carson PE McMurray JJ New England Journal of Medicine0,,:1
7Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE)显示文摘Komajda M Carson PE Hetzel S 2011Circ Heart Fail2011,4,1:1
8Indications for cardiac resynchronization therapy:2011 update from the Heart Failure Society of America Guideline Committee显示文摘Stevenson WG Hernandez AF Carson PE 0,,02:1
9I-PRESERVE Inves- tigators, lrbesartan in patients with heart failure and preserved ejec- tion fraction显示文摘Massie BM Carson PE McMurray JJ 2008N Engl J Med2008,359,23:1
10Indications for cardiac resynchronization therapy:2011 update from the Heart Failure Society of America Guideline Committee 显示文摘Stevenson WG Hernandez AF Carson PE 2012J Card Fail2012,18,2:1
11Irbesartan in patients with heart failure and preserved ejection fraction 显示文摘Massie BM Carson PE McMun'ay J J 2008N Engl J Med2008,359,23:1
12Heart failure with preserved ejection fraction: clinical characteristics of patients enrolled in the I-PRESERVE trial显示文摘McMurray JJ Carson PE Komajda M 2008Eur J Heart Fail2008,10,2:1
13lrbesartan in patients with heart failure and preserved ejection fraction显示文摘Massie BM Carson PE McMurray JJ 2008N Engl J Med2008,359,23:1
14Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction显示文摘Massie BM Carson PE MeMurray JJ 2008New Eng J Med2008,359,23:1
15Heart failure with preserved ejection fraction:clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial显示文摘McMurray JJ Carson PE Komajda M 2008Eur J Heart Fail2008,10,2:1
16Irbesartan in patients with heart failure an perserved ejection fraction显示文摘Massie BM Carson PE Mmurray JJ 0,,23:1
17Indications for car-diac resynchronization therapy: 2011 update from the Heart FailureSociety of America Guideline Committee 显示文摘Stevenson WG Hernandez AF Carson PE 2012J Card Fail2012,18,2:1
18Headache, cerebrovascularsymptoms,and stroke : the Atherosclerosis Risk in Communities Study显示文摘Stang PE Carson AP Rose KM 2005Neurology2005,64,9:1
19Valsartan reducesthe incidence of atrial fibrillation in patients with heartfailure:results from the Valsartan Heart Failure Trial(Val-HeFT)显示文摘Maggioni AP Latini R Carson PE 2005Am Heart J2005,149,3:1
20Irbesartan in Imtients with heart failure and preserved ejection fraction显示文摘Massie BM Carson PE Mcmurray JJ 2008N Engl J Med2008,359,23:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费